SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Canton Hathaway LLC

Canton Hathaway LLC lessened its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 8.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 17,260 shares of the exchange traded fund’s stock after selling 1,685 shares during the quarter. Canton Hathaway LLC’s holdings in SPDR S&P Biotech ETF were worth $1,554,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in XBI. FMR LLC increased its stake in shares of SPDR S&P Biotech ETF by 13.6% in the third quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock worth $686,000 after acquiring an additional 830 shares during the period. Ameritas Advisory Services LLC raised its position in SPDR S&P Biotech ETF by 11.9% during the fourth quarter. Ameritas Advisory Services LLC now owns 10,684 shares of the exchange traded fund’s stock valued at $962,000 after acquiring an additional 1,137 shares in the last quarter. Beaton Management Co. Inc. purchased a new position in SPDR S&P Biotech ETF during the third quarter valued at approximately $212,000. Van ECK Associates Corp acquired a new position in SPDR S&P Biotech ETF in the fourth quarter valued at approximately $1,497,000. Finally, Hollow Brook Wealth Management LLC boosted its position in SPDR S&P Biotech ETF by 4.9% in the 3rd quarter. Hollow Brook Wealth Management LLC now owns 21,669 shares of the exchange traded fund’s stock worth $2,141,000 after purchasing an additional 1,003 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

NYSEARCA:XBI opened at $90.11 on Tuesday. The company has a 50 day moving average price of $91.26 and a 200-day moving average price of $95.97. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47. The firm has a market cap of $6.87 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.